Congress Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-117,762
Closed -$1.31M – 382
2017
Q3
$1.31M Buy
+117,762
New +$1.15M 0.02% 302

Other funds holding NEO

Congress Asset Management's NEO Position: Q4 2017 in Review

Congress Asset Management sold out of NeoGenomics (NEO) in Q4 2017, closing a stake of 117,762 shares — an estimated $1.31M sold.

Congress Asset Management first reported a position in NEO in Q3 2017 and held it in 1 quarter. The position peaked at $1.31M in Q3 2017. 132 funds tracked by Wall St. Rank hold NEO as of Q4 2017.

  • Congress Asset Management reported no remaining NeoGenomics position as of Q4 2017 after selling out during the quarter.
  • Congress Asset Management sold 117,762 NeoGenomics shares in Q4 2017, an estimated $1.31M.
  • Congress Asset Management first reported a position in NeoGenomics in Q3 2017 and held it in 1 quarter.
  • Congress Asset Management's NeoGenomics position peaked at $1.31M in Q3 2017.
  • 132 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2017.

Based on Congress Asset Management's 13F filing for Q4 2017, filed 30 Jan 2018.